Skip to main content
Premium Trial:

Request an Annual Quote

University of California Wins US Patent for Cell-Based Screening Method


The University of California has been awarded US Patent No. 6,911,314, "Screening for drugs that affect TNF receptor releasing enzyme."

Inventors listed on the patent are Tetsuya Gatanaga and Gale Granger.

According to its abstract, the patent protects a procedure by which the biological effects of the cytokine TNF are mediated by binding to receptors on the surface of cells. The patent describes new proteins and polynucleotides that promote enzymatic cleavage and release of TNF receptors, the abstract states. Also protected are methods for identifying additional compounds that influence TNF receptor shedding. As the active ingredient in a pharmaceutical composition, the products of described either increase or decrease TNF signal transduction, thereby alleviating the pathology of disease, the abstract states.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.